1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 8,250 | 8,450 | 25.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Resolutions of the Annual General Meeting 2026 of Bavarian Nordic A/S | 199 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, April 21, 2026 - Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results: The Annual Report for 2025 was adopted. The Board of Directors'... ► Artikel lesen | |
| Mo | Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program | 7 | GlobeNewswire (USA) | ||
| BAVARIAN NORDIC A/S ADR Aktie jetzt für 0€ handeln | |||||
| 16.04. | Bavarian Nordic A/S: Bavarian Nordic Receives Swissmedic Approval for Chikungunya Vaccine | 398 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, April 16, 2026 - Bavarian Nordic A/S (OMX: BAVA) today announced that the Swiss Agency for Therapeutic Products, Swissmedic, has approved VIMKUNYA (recombinant, adsorbed) for active... ► Artikel lesen | |
| 13.04. | Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program | 4 | GlobeNewswire (USA) | ||
| 07.04. | Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program | 9 | GlobeNewswire (USA) | ||
| 30.03. | Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program | 10 | GlobeNewswire (USA) | ||
| 27.03. | Bavarian Nordic A/S: Bavarian Nordic Submits Data to EMA to Extend Mpox and Smallpox Vaccine Approval to Children Aged 2-11 Years | 521 | GlobeNewswire (Europe) | Submission based on topline data from clinical study, demonstrating a comparable safety profile and a non-inferior immune response for MVA-BN in children aged 2-11 years compared to adults.
COPENHAGEN... ► Artikel lesen | |
| 24.03. | Bavarian Nordic A/S - Notice Convening Annual General Meeting | 6 | GlobeNewswire (USA) | ||
| 23.03. | Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program | 9 | GlobeNewswire (USA) | ||
| 16.03. | Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program | 4 | GlobeNewswire (USA) | ||
| 12.03. | Bavarian Nordic A/S: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such | 9 | GlobeNewswire (USA) | ||
| 12.03. | Bavarian Nordic and SII sign agreement for chikungunya vaccine production | 15 | Pharmaceutical Technology | ||
| 12.03. | Bavarian Nordic A/S Full Year Profit Rises | 27 | RTTNews | ||
| 12.03. | Bavarian Nordic A/S: Bavarian Nordic Launches Next Tranche of Share Buy-Back Program | 13 | GlobeNewswire (USA) | ||
| 12.03. | Bavarian Nordic A/S: Bavarian Nordic Publishes Annual Report 2025 | 561 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, March 12, 2026 - Bavarian Nordic A/S (OMX: BAVA) today published its annual report for 2025. The consolidated, audited results were in line with the preliminary results announced... ► Artikel lesen | |
| 11.03. | Bavarian Nordic A/S: Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement | 759 | GlobeNewswire (Europe) | The agreement enables a full tech transfer of the chikungunya vaccine for future supply to low- and middle-income countries.Expanded collaboration provides future co-development opportunities.
COPENHAGEN... ► Artikel lesen | |
| 02.03. | Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover | 13 | FiercePharma | ||
| 02.03. | Bavarian Nordic CEO Paul Chaplin To Resign By Year-End; Stock Down | 4 | RTTNews | ||
| 02.03. | Bavarian Nordic A/S: Paul Chaplin Steps Down as CEO of Bavarian Nordic | 532 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, March 2, 2026 - Bavarian Nordic A/S (OMX: BAVA) announced today, that the Board of Directors has entered into an agreement with CEO, Paul Chaplin, who wishes to step down for personal... ► Artikel lesen | |
| 18.02. | Bavarian Nordic A/S: Bavarian Nordic Receives USD 22.5 Million Contract for its Mpox and Smallpox Vaccine from the Government of Canada | 632 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, February 18, 2026 - Bavarian Nordic A/S (OMX: BAVA) today announced a new order valued at USD 22.5 million from the Public Health Agency of Canada (PHAC) for the Company's mpox... ► Artikel lesen |
1 2 3 4 5 Weiter >>
85 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 90,15 | +0,22 % | Durchbruch in der Psychotherapie: Emyria meldet 50% Remission - Ein neuer "BioNTech-Moment" für die Mental-Health-Branche? | ||
| EVOTEC | 5,350 | -0,93 % | RBC stuft Evotec auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Evotec auf "Outperform" mit einem Kursziel von 10 Euro belassen. Charles Weston passte seine Prognosen und das Bewertungsmodell... ► Artikel lesen | |
| MODERNA | 43,480 | +0,49 % | Moderna, Inc.: Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate | Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat CAMBRIDGE, MA / ACCESS Newswire / April... ► Artikel lesen | |
| PAION | 0,047 | -26,77 % | XFRA MISTRADE ANTRAG IN ISIN DE000A3E5EG5 WURDE STATTGEGEBEN | Dem Mistrade-Antrag wurde stattgegeben. Folgende Geschaefte in der ISIN DE000A3E5EG5, Wertpapier-Name: PAION AG INH O.N., wurden aufgehoben:ISIN Datum Zeit Volumen PreisDE000A3E5EG5 02.02.2026 08:13:40 300 0... ► Artikel lesen | |
| VALNEVA | 2,326 | -0,60 % | Valneva vor kritischer Marke: Droht jetzt der nächste große Absturz? - Was sich am Wochenende verändert hat | ||
| AMGEN | 295,40 | +0,44 % | Amgen Announces Retirement Of David M. Reese, Executive Vice President And Chief Technology Officer | Organizational Changes Further Emphasize Integration of Biology and Technology
THOUSAND OAKS, Calif., April 22, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced... ► Artikel lesen | |
| EPIGENOMICS | 0,930 | 0,00 % | PTA-HV: Epigenomics AG: Einladung zur ordentlichen Hauptversammlung | DJ PTA-HV: Epigenomics AG: Einladung zur ordentlichen Hauptversammlung
Hauptversammlung gemäß -- 121 Abs. 4a AktG
Epigenomics AG: Einladung zur ordentlichen Hauptversammlung
Heidelberg... ► Artikel lesen | |
| NOVAVAX | 6,960 | -0,85 % | Novavax (NVAX) Dips More Than Broader Market: What You Should Know | ||
| STRYKER | 280,10 | +0,21 % | Following Stryker Cyberattack, Avatier Launches Identity Challenge Card to Protect Organizations When Standard Security Fails | New Solution Delivers the First Auto-Enrolled, Air-Gapped Multi-Factor Authentication (MFA) That Can Be Deployed Enterprise-Wide in a Single Day: No Devices, Apps, or Network Connectivity RequiredPLEASANTON... ► Artikel lesen | |
| BIOGEN | 156,62 | -0,43 % | Biogen To Acquire TJ Bio's Rights To Felzartamab In The Greater China Region | WESTON (dpa-AFX) - Biogen Inc. (BIIB) and TJ Biopharma have entered into a definitive agreement under which Biogen has agreed to acquire TJ Bio's exclusive rights to felzartamab in the Greater... ► Artikel lesen | |
| ILLUMINA | 109,30 | +0,15 % | Illumina Expands Collaboration With Labcorp To Advance Precision Oncology | SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN), Wednesday announced an expanded collaboration with Labcorp to advance precision oncology through innovative applications of next-generation sequencing... ► Artikel lesen | |
| CRISPR THERAPEUTICS | 43,400 | +4,25 % | CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy? | ||
| NANOREPRO | 1,485 | -3,26 % | NanoRepro im Umbau: Beteiligungen liefern Wachstum - wird daraus die nächste Consumer-Health-Story? | NanoRepro AG steckt mitten in der Transformation - weg vom klassischen Schnelltestanbieter hin zu einer integrierten Consumer-Health-Plattform. Die Zahlen für 2025 zeigen: Operativ wird bewusst gebremst... ► Artikel lesen | |
| PALATIN TECHNOLOGIES | 21,860 | +4,00 % | Morning Market Movers: Super Micro Computer, Bimergen Energy, Palatin Technologies, Intellicheck See Big Swings | HONG KONG (dpa-AFX) - At 7:40 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| REGENERON PHARMACEUTICALS | 636,20 | -0,80 % | Biotech-Player: Zelltherapie als Comeback-Story im Milliardenmarkt. Neue Ideen nach Corona von BioNTech, Qiagen und Biotech AG |
BAVARIAN NORDIC A/S ADR gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 8,200 Euro und damit -1,20 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BAVARIAN NORDIC A/S ADR finden Sie auf Wallstreet Online.